This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Sep 20;379(12):1188-9.

doi: 10.1056/NEJMc1808907.

Trends in Modern Phase 1 Oncology Trials

Robin L Jones¹

Affiliations

PMID: 30260158
DOI: 10.1056/NEJMc1808907

Comment

Trends in Modern Phase 1 Oncology Trials

Robin L Jones. N Engl J Med. 2018.

. 2018 Sep 20;379(12):1188-9.

doi: 10.1056/NEJMc1808907.

Author

Robin L Jones¹

Affiliation

¹ Royal Marsden Hospital, London, United Kingdom robin.jones4@nhs.net

PMID: 30260158
DOI: 10.1056/NEJMc1808907

No abstract available

PubMed Disclaimer

Comment in

Trends in Modern Phase 1 Oncology Trials.
Italiano A. Italiano A. N Engl J Med. 2018 Sep 20;379(12):1189. doi: 10.1056/NEJMc1808907. N Engl J Med. 2018. PMID: 30231221 No abstract available.

Comment on

Encouraging Trends in Modern Phase 1 Oncology Trials.
Chakiba C, Grellety T, Bellera C, Italiano A. Chakiba C, et al. N Engl J Med. 2018 Jun 7;378(23):2242-2243. doi: 10.1056/NEJMc1803837. N Engl J Med. 2018. PMID: 29874526 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations